Bolt Biotherapeutics (BOLT) Operating Income (2020 - 2025)
Historic Operating Income for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to -$7.7 million.
- Bolt Biotherapeutics' Operating Income rose 5315.33% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.9 million, marking a year-over-year increase of 3946.61%. This contributed to the annual value of -$73.0 million for FY2024, which is 413.15% up from last year.
- Per Bolt Biotherapeutics' latest filing, its Operating Income stood at -$7.7 million for Q3 2025, which was up 5315.33% from -$9.2 million recorded in Q2 2025.
- Bolt Biotherapeutics' 5-year Operating Income high stood at -$7.7 million for Q3 2025, and its period low was -$27.1 million during Q4 2021.
- For the 5-year period, Bolt Biotherapeutics' Operating Income averaged around -$19.1 million, with its median value being -$19.8 million (2023).
- As far as peak fluctuations go, Bolt Biotherapeutics' Operating Income tumbled by 11387.04% in 2021, and later skyrocketed by 5924.24% in 2025.
- Quarter analysis of 5 years shows Bolt Biotherapeutics' Operating Income stood at -$27.1 million in 2021, then increased by 22.29% to -$21.0 million in 2022, then grew by 6.06% to -$19.8 million in 2023, then grew by 14.42% to -$16.9 million in 2024, then skyrocketed by 54.46% to -$7.7 million in 2025.
- Its Operating Income stands at -$7.7 million for Q3 2025, versus -$9.2 million for Q2 2025 and -$12.1 million for Q1 2025.